Table 3.
Differences in DASS-21scores among the study groups
| Variable | Depression Total mean ± SD 2.77 ± 4.34 | Anxiety Total mean ± SD 2.14 ± 3.266 | Stress Total mean ± SD 3.28 ± 4.962 | |||
|---|---|---|---|---|---|---|
| Mean (SD) | P value | Mean (SD) | P value | Mean (SD) | P value | |
| Specialty | 0.038 | 0.01 | 0.011 | |||
| Doctors | 2.42 (4.21) | 1.77 (3.11) | 2.73 (4.67) | |||
| Dentists | 2.76 (4.05) | 2.41 (3.39) | 3.59 (4.96) | |||
| Pharmacists | 3.42 (4.74) | 2.59 (3.36) | 4.02 (5.37) | |||
| Age | 0.048 | 0.034 | 0.002 | |||
| 20 – 29 years | 3.13 (4.54) | 2.49 (3.47) | 3.89 (5.3) | |||
| 30 – 39 years | 2.73 (4.26) | 2.02 (3.08) | 3.20 (4.82) | |||
| 40 years and older | 1.90 (3.90) | 1.58 (3.19) | 1.91 (4.14) | |||
| Gender | 0.404 | 0.187 | 0.605 | |||
| Male | 2.49 (4.07) | 1.81 (3.02) | 3.09 (4.73) | |||
| Female | 2.84 (4.4) | 2.22 (3.32) | 3.33 (5.02) | |||
| Graduation level | 0.028 | 0.059 | 0.002 | |||
| Graduated | 2.96 (4.48) | 2.26 (3.31) | 3.58 (5.06) | |||
| Postgraduates | 2.10 (3.84) | 1.71 (3.06) | 2.22 (4.46) | |||
| Years of Experience | 0.195 | 0.176 | 0.065 | |||
| Less than 5 years | 2.76 (4.16) | 2.12 (3.05) | 3.43 (5.06) | |||
| 5 – 9 years | 2.93 (4.64) | 2.19 (3.36) | 3.47 (4.97) | |||
| 10 – 14 years | 3.17 (4.59) | 2.54 (3.64) | 3.74 (5.21) | |||
| 15 – 19 years | 2.45 (4.25) | 1.94 (3.71) | 2.18 (4.35) | |||
| 20 years and more | 1.63 (3.41) | 1.32 (2.60) | 1.92 (4.14) | |||
| Vaccination status | 0.024 | 0.176 | 0.006 | |||
| First dose only | 3.47 (4.69) | 2.46 (3.99) | 4.26 (5.98) | |||
| Two doses | 2.57 (4.22) | 2.05 (3.04) | 3.01 (4.61) | |||
| Type of vaccine | 0.016 | 0.039 | 0.022 | |||
| Sinopharm | 1.82 (3.69) | 1.50 (2.76) | 2.26 (4.38) | |||
| AstraZeneca | 3.18 (4.85) | 2.39 (3.61) | 3.80 (5.55) | |||
| Pfizer | 2.91 (4.29) | 2.25 (3.26) | 3.41 (4.85) | |||
| Symptoms | 0.000 | 0.000 | 0.000 | |||
| Yes | 3.26 (4.53) | 2.60 (3.56) | 3.82 (5.23) | |||
| No | 1.52 (3.53) | 0.98 (1.91) | 1.91 (3.88) | |||
| Onset of symptoms* | 0.473 | 0.280 | 0.663 | |||
| After 1st dose | 3.24 (4.46) | 2.40 (3.60) | 3.69 (5.38) | |||
| After 2nd dose | 2.78 (4.50) | 2.29 (3.18) | 3.48 (5.14) | |||
| After 1st & 2nd dose | 3.46 (4.79) | 2.86 (3.59) | 4.02 (5.02) | |||
| History of infection | 0.021 | 0.011 | 0.208 | |||
| Infected | 3.15 (4.66) | 2.43 (3.47) | 3.55 (5.16) | |||
| Not infected | 2.44 (4.03) | 1.89 (3.07) | 3.05 (4.78) | |||
| Corticosteroid use ** | 0.515 | 0.815 | 0.701 | |||
| Yes | 3.41 (4.89) | 2.46 (3.5) | 3.89 (5.55) | |||
| No | 2.98 (4.46) | 2.35 (3.36) | 3.6 (5.12) | |||
*
n=526,
**
n=520